Quiz: Help Us Take The Pulse Of Our Readers
Even the most exalted among us realize health care policy is complicated. Here's a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
Health Industry
2,601-2,620 of 4,017 results
-
-
Overwrought Marketing? Ads, Not Research, Create Some Pharma Best-Sellers
A look at how and why strategic, star-studded advertising brought a drug for a little-known neurological condition into your home.
-
Houston Hospital Checking To See If Patients’ Cupboards Are Bare
Starting in fall 2015, Houston-based Memorial Hermann Health System began to examine the food struggles among patients at four medical sites and found that 11 percent to 30 percent said they had run out of food in the prior month or thought that they would.
-
Grassley, Chaffetz Send Fiery Response To HHS Memo They Say Chills Whistleblowing
The two Republican lawmakers sent a letter to HHS Secretary Tom Price warning him that whistleblowers in HHS could be intimidated into silence by a department memo instructing employees to get clearance before talking with members of Congress and their staffs.
By Rachel Bluth -
Nearly 1 In 3 Recent FDA Drug Approvals Followed By Major Safety Actions
More than 70 drugs approved from 2001 through 2010 ran into safety concerns later that resulted in withdrawals from the market, 鈥渂lack box鈥 warnings or other actions.
-
Should Health Care Trainees Be Treated As Paid Employees?
A bill pending in California鈥檚 Legislature, sponsored by an influential health care union, would require hospitals and clinics to pay minimum wage to student trainees.
By Anna Gorman -
REPEAL & REPLACE WATCH
Political Theater: How A Bill That Nearly All Opposed Managed To Pass The House
House Republicans can say they kept their campaign promise to replace Obamacare, but they鈥檙e counting on the Senate to backstop them.
-
Repeal & Replace Watch
Blue Shield CEO Says GOP鈥檚 鈥楩lawed鈥 Health Bill Would Harm Sicker Consumers
CEO Paul Markovich said he opposes the Republican plan because it would allow insurers to once again discriminate against people with preexisting conditions. "We are better than that," he said.
By Chad Terhune -
Urgent Care Sites Cater To Cancer Patients, Letting Them Check Some Worries At Door
Hospitals and oncology practices are setting up urgent care services aimed specifically at cancer patients to help keep them out of the hospital.
-
Volunteers Help Ombudsmen Give Nursing Home Residents 鈥楢 Voice鈥 In Their Care
Ombudsman's offices represent long-term care residents on issues such as admissions and discharges, food, physical environment and abuse.
By Susan Jaffe -
Exodus By Puerto Rican Medical Students Deepens Island鈥檚 Doctor Drain
Interest in medical schools is high in Puerto Rico, but many students look to the U.S. mainland for residencies because of higher pay and the commonwealth's declining economy. The migration of young talent is both a symptom and an exacerbation of the island鈥檚 medical woes.
-
Rural Doctors鈥 Training May Be In Jeopardy
A program designed to address the shortage of doctors in rural and poor urban areas could be in peril unless Congress acts.
-
TREATING CANCER: HOPE VS. HYPE
Widespread Hype Gives False Hope To Many Cancer Patients
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
By Liz Szabo -
Severe Shortage Of Home Health Workers Robs Thousands Of Proper Care
A critical shortage of home health care workers across the U.S. is denying care for senior citizens and people with disabilities.
-
Health Care In America: An Employment Bonanza And A Runaway-Cost Crisis
The Trump administration has pledged to create jobs and shrink health care spending聽鈥 almost a contradiction in a country where health care is a roaring engine of the economy.
By Chad Terhune -
A Spoonful Of Kids鈥 Medicine Makes The Profits Go Up
Even as drug pricing issues continue to draw scrutiny, federal safety regulations and incentives offer drug companies a new avenue to get a sweet return on their development costs.
-
Drugmakers Dramatically Boosted Lobbying Spending In Trump鈥檚 First Quarter
With high drug prices creating widespread controversy, top pharmaceutical companies and their trade group vastly increased their lobbying spending on Capitol Hill.
-
Marathon Pharmaceutical Drops Out Of PhRMA Following Drug Price Controversy
Two companies that faced criticism for high-priced drugs, Marathon and Mallinckrodt, have dropped out of the PhRMA trade association.
-
What Doesn’t Kill You Can Maim: Unexpected Injuries From Opioids
Doctors are beginning to pay attention to injuries, such as brain damage or kidney failure, that can afflict people who survive an overdose.
-
For Doctors, A Clamp Down On Visas Could Have An Uneven Effect In The U.S.
New research shows that physicians getting H-1B visas account for just over 1 percent of all doctors, but some areas are much more likely to be seeking their services.